Quest Diagnostics Inc
NYSE:DGX
Quest Diagnostics Inc
NYSE:DGX
Price:
142.48 USD
1.21%
Updated:
May 16, 2024
Quest Diagnostics Inc
Income from Continuing Operations
|
Quest Diagnostics Inc
Income from Continuing Operations Peer Comparison
Comparables:
DVA
CHE
CVS
CI
LH
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Income from Continuing Operations
$870m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
4%
|
CAGR 10-Years
0%
|
|
|
DaVita Inc
NYSE:DVA
|
Income from Continuing Operations
$1.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
2%
|
|
|
Chemed Corp
NYSE:CHE
|
Income from Continuing Operations
$283.4m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
|
CVS Health Corp
NYSE:CVS
|
Income from Continuing Operations
$7.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
|
Cigna Corp
NYSE:CI
|
Income from Continuing Operations
$3.9B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Income from Continuing Operations
$400.3m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-3%
|
See Also
What is Quest Diagnostics Inc's Income from Continuing Operations?
Income from Continuing Operations
870m
USD
870m
USD
Based on the financial report for Mar 31, 2024, Quest Diagnostics Inc's Income from Continuing Operations amounts to 870m USD.
What is Quest Diagnostics Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
0%
0%
Over the last year, the Income from Continuing Operations growth was 3%. The average annual Income from Continuing Operations growth rates for Quest Diagnostics Inc have been -22% over the past three years , 4% over the past five years .
You don't have any saved screeners yet
